Cyclodextrin glycosyltransferase (CGTase) is an enzyme that produces cyclodextrins (CDs) from starch and related carbohydrates, producing a mixture of α-, β-, and γ-CDs in different amounts. CGTase production, mainly by sp., depends on fermentation conditions such as pH, temperature, concentration of nutrients, carbon and nitrogen sources, among others. CGTase produces those three types of CDs, however, β-CD should prevail. Although, waxy corn starch (CS) is used industrially to obtain CGTase and CDs because of its high amylopectin content, alternative sources such as amaranth starch (AS) could be used to accomplish those purposes. AS has high susceptibility to the amylolytic activity of CGTase because of its 80% amylopectin content. Therefore, the aim of this work was evaluate the AS as carbon source for CGTase production by in a submerged fermentation. Afterwards, the CGTase was purified partially and its activity to synthesize α-, β-, and γ-CDs was evaluated using 1% AS as substrate. produced a 66 kDa CGTase (Topt = 50°C; pHopt = 8.0), from the early exponential growth phase which lasted 36 h. The maximum CGTase specific activity (106.62 ± 8.33 U/mg protein) was obtained after 36 h of culture. CGTase obtained with a Km = 0.152 mM and a Vmax = 13.4 μM/min yielded 40.47% total CDs using AS which was roughly twice as much as that of corn starch (CS; 24.48%). High costs to produce CDs in the pharmaceutical and food industries might be reduced by using AS because of its higher α-, β- and γ-CDs production (12.81, 17.94, and 9.92%, respectively) in a shorter time than that needed for CS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033961PMC
http://dx.doi.org/10.3389/fmicb.2016.01513DOI Listing

Publication Analysis

Top Keywords

α- β-
12
β- γ-cds
12
cgtase
10
amaranth starch
8
cyclodextrin glycosyltransferase
8
cgtase production
8
corn starch
8
amylopectin content
8
starch
5
cds
5

Similar Publications

Correlation between polymorphisms of gene and renal injury in patients with type 2 diabetes mellitus.

Zhong Nan Da Xue Xue Bao Yi Xue Ban

July 2024

Department of Nephrology, Third Xiangya Hospital, Central South University, Changsha 410013.

Objectives: Genetic factors play an important role in the pathogenesis of diabetic kidney disease (DKD). Studies have shown that gene polymorphism is associated with the pathogenesis of type 2 diabetes mellitus (T2DM), but its role in DKD remains unclear. This study aims to analyze the distribution of alleles and genotypes of gene in patients with T2DM, and investigate the association between genetic polymorphism and DKD susceptibility in T2DM patients, which may provide new ideas for the pathogenesis of DKD.

View Article and Find Full Text PDF

The main purpose of this study is to characterize the nature of the low-energy singlet excited states of the anthranilic acid homodimer (AA) and their changes (symmetry breaking) caused by deformation of the centrosymmetric, ground state structure of AA towards the geometry of the S state. We employ both the correlated ab initio methods (approximate Coupled Clusters Singles and Doubles-CC2 and CASSCF/NEVPT2) as well as the DFT/TDDFT calculations with two exchange-correlation functionals, i.e.

View Article and Find Full Text PDF

The concept of non-trivial electronic structure combined with reduced dimensionality presents a promising strategy for advancing optical applications and energy harvesting technologies. Symmetry breaking in low dimensional system enables the emergence of non-linear optical responses, which are greatly amplified by the singular points of band inversion. Here, using first-principles calculations, the significant enhancement of the shift current in Bi nanotubes is investigated, driven by the combined effects of 1D geometry and non-trivial band order.

View Article and Find Full Text PDF

Outcomes of down-titration in patients with severe scalp alopecia areata initially treated with baricitinib 4-mg: Week 152 data from BRAVE-AA2.

J Am Acad Dermatol

October 2024

Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Experimental, Diagnostic and Specialty Medicine Alma Mater Studiorum, University of Bologna, Bologna, Italy.

Background: Baricitinib, an oral selective Janus kinase inhibitor, is approved to treat adults with severe alopecia areata (AA).

Objective: To report the week 152 efficacy results from the phase 3 trial BRAVE-AA2 down-titration substudy.

Methods: BRAVE-AA2 enrolled 546 adults with severe AA (Severity of Alopecia Tool [SALT] score ≥50).

View Article and Find Full Text PDF
Article Synopsis
  • * A systematic review and Bayesian network meta-analysis were conducted, analyzing existing randomized controlled trials (RCTs) to evaluate the efficacy and safety of these two drugs at Week 24.
  • * The results indicated no significant difference in hair regrowth effectiveness between ritlecitinib and baricitinib, but highlighted the need for more research due to uncertainty and effect modifications found in the analysis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!